In a filing, MoonLake Immunotherapeutics revealed its Chief Executive Officer Santos da Silva Jorge unloaded Company’s shares for reported $1.96 million on Dec 08 ’25. In the deal valued at $15.08 per share,130,000 shares were sold. As a result of this transaction, Santos da Silva Jorge now holds 2,948,577 shares worth roughly $54.52 million.
Then, Santos da Silva Jorge sold 70,000 shares, generating $1,014,300 in total proceeds. Upon selling the shares at $14.49, the Chief Executive Officer now owns 2,878,577 shares.
Before that, Reich Kristian sold 130,000 shares. MoonLake Immunotherapeutics shares valued at $1,960,400 were divested by the Chief Scientific Officer at a price of $15.08 per share. As a result of the transaction, Reich Kristian now holds 72,908 shares, worth roughly $1.35 million.
BTIG Research upgraded its MoonLake Immunotherapeutics [MLTX] rating to a Buy from a a Neutral in a research note published recently. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who increased its forecast for the stock in early November from “a Neutral” to “a Buy”. H.C. Wainwright also remained covering MLTX and has decreased its forecast on October 02, 2025 with a “Neutral” recommendation from previously “Buy” rating. Goldman revised its rating on October 01, 2025. It rated MLTX as “a Neutral” which previously was an “a Buy”.
Price Performance Review of MLTX
On Monday, MoonLake Immunotherapeutics [NASDAQ:MLTX] saw its stock jump 28.94% to $18.49. Over the last five days, the stock has gained 54.73%. MoonLake Immunotherapeutics shares have fallen nearly -63.17% since the year began. Nevertheless, the stocks have risen 40.29% over the past one year.
How much short interest is there in MoonLake Immunotherapeutics?
A steep rise in short interest was recorded in MoonLake Immunotherapeutics stocks on 2025-12-15, growing by 1.04 million shares to a total of 4.89 million shares. Yahoo Finance data shows the prior-month short interest on 2025-11-14 was 3.86 million shares. There was a rise of 21.21%, which implies that there is a positive sentiment for the stock.
